However, it has been recently suggested that TDF blocks Pannexin-1, which results in decreased adenosine levels and hence diminishes adenosine a2 receptor (A2AR)-mediated skin and liver fibrosis [43]. Here, ADORA2A is linked to Hepatic fibrosis.